Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
ASPIRO: A Phase 1/2, Randomized, Open-Label, Ascending-Dose, Delayed-Treatment Concurrent Control Clinical Study to Evaluate the Safety and Preliminary Efficacy of AT132, an AAV8-Delivered Gene Therapy in X-Linked Myotubular My
Kuntz, Nancy L
(PD/PI)
Pediatrics
Project
:
Research project
Overview
Project Details
Status
Active
Effective start/end date
9/7/17
→
8/31/50
Funding
Audentes Therapeutics, Inc.
View all
View less